Aethlon Medical (AEMD) Tops Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Aethlon Medical Announces First Quarter Fiscal Year 2019 Results
August 8, 2018 4:15 PM EDTSAN DIEGO, Aug. 8, 2018 /PRNewswire/ --Â Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced results for its fiscal first quarter ended June 30, 2018.
First Quarter Financial Results
At June 30, 2018, the Company had a cash balance of approximately $6.1 million.
The Company's net loss was approximately $1.1 million, or $(0.06) per share for the three months ended June 30, 2018 compared to a net loss of approximately $1.8 million, or $(0.21) for the three months ended June 30, 2017.
During the three months ended June 30, 2018, the... More
